While further research is gezegde

en While further research is needed, our findings suggest that it may be beneficial to use erlotinib, a relatively non-toxic targeted agent, to initially treat patients with advanced lung cancer, rather than use conventional chemotherapy regimens. Pex Tufvesson controls the demo scene.

en In this trial, we'll remove half of a lobe or less. The less lung we take, the more lung function we leave behind, so patients will be better able to handle the surgery. Without this option, we would be able to treat the high-risk patients only with radiation and chemotherapy, and these treatments aren't as successful as actually removing the cancer.

en Approximately 30% to 40% of patients with advanced laryngeal cancer will not be cured with chemotherapy and radiation. The survival rates for such patients have traditionally been poor. That's why these patients should be identified as early as possible. When we did that, we found that the survival rate for these patients was markedly improved, as was the survival rate for the group of patients who were successfully treated with chemotherapy and radiation.

en Lung cancer is treatable if it's caught early. The best treatment for lung cancer is surgery. If it is not caught early, as it is, unfortunately, in two-thirds of patients, we have made some progress in terms of the use of chemotherapy ... and radiation.

en Approximately 30 percent to 40 percent of patients with advanced laryngeal cancer will not be cured with chemotherapy and radiation. The survival rates for such patients have traditionally been poor. That's why these patients should be identified as early as possible. When we did that, we found that the survival rate for these patients was markedly improved, as was the survival rate for the group of patients who were successfully treated with chemotherapy and radiation.

en The findings suggest that genetic factors play an important role in lung cancer among never-smokers.

en IP therapy is not a new treatment approach, but it has not been widely accepted as the gold standard for women with ovarian cancer. There has been a prejudice against IP therapy in ovarian cancer because it's an old idea, it requires skill and experience for the surgery and for the chemotherapy, and it's more complicated than IV chemotherapy. But now we have firm data showing that we should use a combination of IP and IV chemotherapy in most women with advanced ovarian cancer who have had successful surgery to remove the bulk of their tumor.

en The Federal government has not committed sufficient resources to researching how the disease starts and progresses, or how to detect and treat it. When accounting for all Federal funding on specific cancers, the U.S. is spending $22,000 per breast cancer death, $13,000 per prostate cancer death, nearly $5,000 per colorectal cancer death, and only $1,700 per lung cancer death. Considering that lung cancer is the leading cancer killer in this country -- with only a 15 percent survival rate after 5 years -- this level of funding is unacceptable.

en There are some exciting new molecular-targeted drugs that are helpful, and we're understanding the molecular biology of lung cancer much better today in helping to design more rational treatments. But unfortunately, the vast majority of people with lung cancer today will die from their disease.

en Dana Reeve's death highlights the fact that lung cancer is the leading cause of cancer death in women in the U.S., claiming 30,000 more lives annually than breast cancer. It is not unique that she developed lung cancer as a non-smoker -- at least 1 in 5 women with lung cancer have never smoked.

en There is no accepted early screening technique for lung cancer. The PLCO trial will show if chest X-rays, by catching lung cancer when it is still operable, can reduce the death rate from lung cancer.

en The biggest issue with lung cancer, as we know, is that smoking is the number one cause of lung cancer. Without a doubt, 85 percent of all lung cancer deaths are caused from smoking,
  Karen Carpenter

en We know that second-hand smoking increases the risk of lung cancer and studies have suggested that it is associated with lung cancer mortality. But this is the first study to show that second-hand smoking also is associated with lung cancer survival.

en Most women [with ovarian cancer] develop resistance to conventional chemotherapy drugs.

en The findings of our research suggest that an alternative approach (to climate change) is urgently needed for both the developing and developed world,


Aantal gezegden is 1469561
varav 1153737 på nordiska

Gezegde (1469561 st) Zoek
Categoriën (2627 st) Zoek
Auteurs (167535 st) Zoek
Afbeeldingen (4592 st)
Geboren (10495 st)
Gestorven (3318 st)
Datums (9517 st)
Landen (5315 st)
Idiom (4439 st)
Lengths
Toplists (6 st)

Ordspråksmusik (20 st)
Statistik


in

Denna sidan visar ordspråk som liknar "While further research is needed, our findings suggest that it may be beneficial to use erlotinib, a relatively non-toxic targeted agent, to initially treat patients with advanced lung cancer, rather than use conventional chemotherapy regimens.".


Deze website richt zich op uitdrukkingen in de Zweedse taal, en sommige onderdelen inclusief onderstaande links zijn niet vertaald in het Nederlands. Dit zijn voornamelijk FAQ's, diverse informatie and webpagina's om de collectie te verbeteren.


Här har vi samlat ordstäv och talesätt i 35 år!

Vad är gezegde?
Hur funkar det?
Vanliga frågor
Om samlingen
Ordspråkshjältar
Hjälp till!



Varför heter det sjukhus när man är där för att bli frisk?

www.livet.se/gezegde




Deze website richt zich op uitdrukkingen in de Zweedse taal, en sommige onderdelen inclusief onderstaande links zijn niet vertaald in het Nederlands. Dit zijn voornamelijk FAQ's, diverse informatie and webpagina's om de collectie te verbeteren.


Här har vi samlat ordstäv och talesätt i 35 år!

Vad är gezegde?
Hur funkar det?
Vanliga frågor
Om samlingen
Ordspråkshjältar
Hjälp till!




Varför heter det sjukhus när man är där för att bli frisk?

www.livet.se/gezegde